|
G |
Casp2 |
caspase 2 |
increases expression multiple interactions decreases expression |
ISO |
tetraiodothyroacetic acid results in increased expression of CASP2 mRNA heteronemin inhibits the reaction [tetraiodothyroacetic acid results in increased expression of CASP2 mRNA]; heteronemin promotes the reaction [tetraiodothyroacetic acid results in decreased expression of CASP2 mRNA]; tetraiodothyroacetic acid inhibits the reaction [heteronemin results in decreased expression of CASP2 mRNA] |
CTD |
PMID:35151786 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
ISO |
tetraiodothyroacetic acid results in increased expression of CASP3 protein modified form heteronemin promotes the reaction [tetraiodothyroacetic acid results in increased expression of CASP3 protein modified form]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in increased expression of CASP3 protein modified form] |
CTD |
PMID:35151786 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
ISO |
[tetraiodothyroacetic acid affects the susceptibility to heteronemin] which results in increased expression of CASP8 protein modified form; heteronemin promotes the reaction [tetraiodothyroacetic acid results in increased expression of CASP8 protein modified form] tetraiodothyroacetic acid results in increased expression of CASP8 protein; tetraiodothyroacetic acid results in increased expression of CASP8 protein modified form |
CTD |
PMID:35151786 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions decreases expression |
ISO |
tetraiodothyroacetic acid inhibits the reaction [heteronemin results in increased expression of CASP9 protein modified form] tetraiodothyroacetic acid results in decreased expression of CASP9 protein |
CTD |
PMID:35151786 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
tetraiodothyroacetic acid results in decreased expression of CCND1 mRNA [heteronemin affects the susceptibility to tetraiodothyroacetic acid] which results in decreased expression of CCND1 protein; [tetraiodothyroacetic acid affects the susceptibility to heteronemin] which results in decreased expression of CCND1 mRNA; [tetraiodothyroacetic acid affects the susceptibility to heteronemin] which results in increased expression of CCND1 protein; heteronemin inhibits the reaction [tetraiodothyroacetic acid results in decreased expression of CCND1 mRNA]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in decreased expression of CCND1 protein] |
CTD |
PMID:35151786 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression multiple interactions |
ISO |
tetraiodothyroacetic acid results in decreased expression of CDKN1A mRNA tetraiodothyroacetic acid results in increased expression of CDKN1A mRNA heteronemin inhibits the reaction [tetraiodothyroacetic acid results in decreased expression of CDKN1A mRNA]; heteronemin inhibits the reaction [tetraiodothyroacetic acid results in increased expression of CDKN1A mRNA]; tetraiodothyroacetic acid inhibits the reaction [heteronemin affects the expression of CDKN1A mRNA]; tetraiodothyroacetic acid inhibits the reaction [heteronemin results in decreased expression of CDKN1A mRNA] |
CTD |
PMID:35151786 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression multiple interactions |
ISO |
tetraiodothyroacetic acid results in increased expression of CYCS protein tetraiodothyroacetic acid promotes the reaction [heteronemin results in increased expression of CYCS protein] |
CTD |
PMID:35151786 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Kdr |
kinase insert domain receptor |
decreases phosphorylation |
ISO |
tetraiodothyroacetic acid results in decreased phosphorylation of KDR protein |
CTD |
PMID:35151786 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases expression |
ISO EXP |
[heteronemin affects the susceptibility to tetraiodothyroacetic acid] which results in decreased expression of MAPK1 protein modified form; heteronemin promotes the reaction [tetraiodothyroacetic acid results in decreased expression of MAPK1 protein modified form]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in decreased expression of MAPK1 protein modified form] tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of MAPK1 protein] |
CTD |
PMID:17984113 PMID:35151786 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases expression |
ISO EXP |
[heteronemin affects the susceptibility to tetraiodothyroacetic acid] which results in decreased expression of MAPK3 protein modified form; heteronemin promotes the reaction [tetraiodothyroacetic acid results in decreased expression of MAPK3 protein modified form]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in decreased expression of MAPK3 protein modified form] tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of MAPK3 protein] |
CTD |
PMID:17984113 PMID:35151786 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
ISO |
tetraiodothyroacetic acid results in decreased expression of MMP9 mRNA heteronemin inhibits the reaction [tetraiodothyroacetic acid results in decreased expression of MMP9 mRNA]; tetraiodothyroacetic acid inhibits the reaction [heteronemin results in increased expression of MMP9 mRNA] |
CTD |
PMID:35151786 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
tetraiodothyroacetic acid promotes the reaction [THRA protein binds to NCOA2 protein]; tetraiodothyroacetic acid promotes the reaction [THRB protein binds to NCOA2 protein] |
CTD |
PMID:31566444 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
tetraiodothyroacetic acid inhibits the reaction [Thyroxine inhibits the reaction [THRB protein binds to NCOR1 protein]]; tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine inhibits the reaction [THRB protein binds to NCOR1 protein]] |
CTD |
PMID:22227104 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ncor2 |
nuclear receptor co-repressor 2 |
multiple interactions |
ISO |
tetraiodothyroacetic acid inhibits the reaction [Thyroxine inhibits the reaction [THRB protein binds to NCOR2 protein]]; tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine inhibits the reaction [THRB protein binds to NCOR2 protein]] |
CTD |
PMID:22227104 |
|
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
tetraiodothyroacetic acid binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression increases expression |
ISO |
[tetraiodothyroacetic acid affects the susceptibility to heteronemin] which results in increased expression of PCNA protein; heteronemin inhibits the reaction [tetraiodothyroacetic acid results in increased expression of PCNA protein]; heteronemin promotes the reaction [tetraiodothyroacetic acid results in decreased expression of PCNA mRNA]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in decreased expression of PCNA mRNA] |
CTD |
PMID:35151786 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Rxra |
retinoid X receptor alpha |
affects binding |
ISO |
tetraiodothyroacetic acid binds to RXRA protein |
CTD |
PMID:31566444 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases expression |
ISO |
[heteronemin co-treated with tetraiodothyroacetic acid] results in decreased expression of STAT3 protein tetraiodothyroacetic acid results in decreased expression of STAT3 protein modified form |
CTD |
PMID:35151786 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
tetraiodothyroacetic acid binds to and results in increased activity of THRA protein; tetraiodothyroacetic acid promotes the reaction [THRA protein binds to NCOA2 protein] |
CTD |
PMID:31566444 PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions increases activity affects binding |
ISO |
tetraiodothyroacetic acid binds to and results in increased activity of THRB protein; tetraiodothyroacetic acid inhibits the reaction [Thyroxine inhibits the reaction [THRB protein binds to NCOR1 protein]]; tetraiodothyroacetic acid inhibits the reaction [Thyroxine inhibits the reaction [THRB protein binds to NCOR2 protein]]; tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine inhibits the reaction [THRB protein binds to NCOR1 protein]]; tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine inhibits the reaction [THRB protein binds to NCOR2 protein]]; tetraiodothyroacetic acid promotes the reaction [THRB protein binds to NCOA2 protein] tetraiodothyroacetic acid results in increased activity of THRB protein tetraiodothyroacetic acid binds to THRB protein |
CTD |
PMID:22227104 PMID:31077750 PMID:31566444 PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions decreases expression |
EXP ISO |
tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of TP53 protein modified form] tetraiodothyroacetic acid results in decreased expression of TP53 mRNA [heteronemin affects the susceptibility to tetraiodothyroacetic acid] which results in decreased expression of TP53 mRNA; heteronemin promotes the reaction [tetraiodothyroacetic acid results in decreased expression of TP53 mRNA]; tetraiodothyroacetic acid promotes the reaction [heteronemin results in decreased expression of TP53 mRNA] |
CTD |
PMID:17984113 PMID:35151786 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|